Skip to main content
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Managed Care
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Managed Care
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Jiménez M. Navalón
Fluoropyrimidine- and irinotecan-induced toxicity profile associated with mutations in DPYD and UGT1A1 genes
Background Fluoropyrimidines are a mainstay in the treatment of gastrointestinal tumours (GIT), although they can sometimes produce severe toxicity, usually related to p...
Brage E. Terán ;
Tocino R. Vidal ;
García B. Cigarral ;
Sánchez E. Fonseca ;
Martín M. Navarro ;
Jung D. Heredero ;
Berrocal B. García ;
Jiménez M. Navalón ;
06/27/2022
Featured CME
The Medication Access and Training Expansion (MATE) Act requires prescribers renewing their DEA registration to have completed at least 8 hours of training on opioid or other substance use disorders.
Upcoming Events
April 3 – April 4
April 5 – April 6
April 21 – April 24
April 29 – April 30
April 30 – May 4
May 1 – May 2
May 7 – May 9
May 8 – May 10
May 14 – May 16
May 19 – May 21
See Full Calendar